Dow Up 1.30% Nasdaq Up 0.37%

RXi Pharmaceuticals Corporation (RXII)

-NasdaqCM
2.05 0.04(1.91%) Oct 30, 4:00PM EDT
Prev Close:2.09
Open:2.10
Bid:1.51 x 100
Ask:2.22 x 700
1y Target Est:10.17
Beta:2.04
Next Earnings Date:N/A
Day's Range:1.97 - 2.10
52wk Range:1.64 - 6.84
Volume:141,388
Avg Vol (3m):520,280
Market Cap:33.01M
P/E (ttm):N/A
EPS (ttm):-1.16
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for RXII

Comparison

Symbol% ChgMkt Cap
RXIIDown 1.91%33.01M
AGN56.24B
ALNY7.23B
MRNA23.90M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):207.75
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.95
Quarterly EPS Est (Sep-14) :-0.22
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

RXi Pharmaceuticals Corporation, a biotechnology company, focuses on discovering, developing, and commercializing therapies based on its proprietary, next-generation RNA interference (RNAi) platform. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback